Hypervascular Liver Lesions

Seminars in Ultrasound, CT and MRI

Volumn 30, Issue 5, 2009, Pages 387-407

  Kamaya, Aya ^a   Maturen, Katherine E ^b   Tye, Grace A ^a   Liu, Yueyi I ^c   Parti, Naveen N ^d   Desser, Terry S ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c STANFORD UNIVERSITY   (United States)

^d Greenville Radiology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOSARCOMA; ARTICLE; BILE DUCT CARCINOMA; CAVERNOUS HEMANGIOMA; COLOR ULTRASOUND FLOWMETRY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIFFERENTIAL DIAGNOSIS; GLOMUS TUMOR; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; LIVER ADENOMA; LIVER BLOOD FLOW; LIVER CARCINOMA; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER METASTASIS; LIVER NODULE; NODULAR HYPERPLASIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PELIOSIS HEPATIS; PORTOSYSTEMIC ANASTOMOSIS; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RENDU OSLER WEBER DISEASE; RISK FACTOR; VASCULAR DISEASE; XANTHOGRANULOMA;

DIAGNOSIS, DIFFERENTIAL; HUMANS; LIVER; LIVER DISEASES; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; NEOVASCULARIZATION, PATHOLOGIC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 70349189435     PISSN: 08872171     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.sult.2009.06.001     Document Type: Article

References (140)

1. Baron R.L. Understanding and optimizing use of contrast material for CT of the liver. AJR Am J Roentgenol 163 (1994) 323-331
2. Goshima S., Kanematsu M., Kondo H., et al. Optimal acquisition delay for dynamic contrast-enhanced MRI of hypervascular hepatocellular carcinoma. AJR Am J Roentgenol 192 (2009) 686-692
3. Mori K., Yoshioka H., Takahashi N., et al. Triple arterial phase dynamic MRI with sensitivity encoding for hypervascular hepatocellular carcinoma: Comparison of the diagnostic accuracy among the early, Middle, late, and whole triple arterial phase imaging. AJR Am J Roentgenol 184 (2005) 63-69
4. Yoshioka H., Sato J., Takahashi N., et al. Dual double arterial phase dynamic MR imaging with sensitivity encoding (SENSE): Which is better for diagnosing hypervascular hepatocellular carcinomas, in-phase or opposed-phase imaging?. Magn Reson Imaging 22 (2004) 361-367
5. Murakami T., Kim T., Takamura M., et al. Hypervascular hepatocellular carcinoma: Detection with double arterial phase multi-detector row helical CT. Radiology 218 (2001) 763-767
6. Fleischmann D., and Kamaya A. Optimal vascular and parenchymal contrast enhancement: The current state of the art. Radiol Clin North Am 47 (2009) 13-26
7. Nguyen B.N., Flejou J.F., Terris B., et al. Focal nodular hyperplasia of the liver: A comprehensive pathologic study of 305 lesions and recognition of new histologic forms. Am J Surg Pathol 23 (1999) 1441-1454
8. Craig Jr. P.R., and Edmondson H.A. Tumors of the liver and intrahepatic bile ducts. Atlas of Tumor Pathology, Second Series Fascicle (1989), Armed Forces Institute of Pathology, Washington, DC 26 Pathology AFIo, editor.
9. Party I.W. Terminology of nodular hepatocellular lesions. J Hepatol 22 (1995) 983-993
10. Vilgrain V. Focal nodular hyperplasia. Eur J Radiol 58 (2006) 236-245
11. Cotran R.S., Kumar V., and Collins T. Robbins Pathologic Basis of Disease (1999), WB Saunders, Philadelphia, PA
12. Hussain S.M., Terkivatan T., Zondervan P.E., et al. Focal nodular hyperplasia: Findings at state-of-the-art MR imaging, US, CT, and pathologic analysis. RadioGraphics 24 (2004) 3-17 discussion, 18-19
13. Wanless I.R., Mawdsley C., and Adams R. On the pathogenesis of focal nodular hyperplasia of the liver. J Hepatol 5 (1985) 1194-1200
14. Paradis V., Benzekri A., Dargere D., et al. Telangiectatic focal nodular hyperplasia: A variant of hepatocellular adenoma. Gastroenterology 126 (2004) 1323-1329
15. Bioulac-Sage P., Rebouissou S., Sa Cunha A., et al. Clinical, morphologic, and molecular features defining so-called telangiectatic focal nodular hyperplasias of the liver. Gastroenterology 128 (2005) 1211-1218
16. Paradis V., Champault A., Ronot M., et al. Telangiectatic adenoma: An entity associated with increased body mass index and inflammation. J Hepatol 46 (2007) 140-146
17. Kehagias D., Moulopoulos L., Antoniou A., et al. Focal nodular hyperplasia: Imaging findings. Eur Radiol 11 (2001) 202-212
18. Uggowitzer M., Kugler C., Machan L., et al. Power Doppler imaging and evaluation of the resistive index in focal nodular hyperplasia of the liver. Abdom Imaging 22 (1997) 268-273
19. Kim M.J., Lim H.K., Kim S.H., et al. Evaluation of hepatic focal nodular hyperplasia with contrast-enhanced gray scale harmonic sonography: Initial experience. J Ultrasound Med 23 (2004) 297-305
20. Rogers J.V., Mack L.A., Freeny P.C., et al. Hepatic focal nodular hyperplasia: Angiography, CT, sonography, and scintigraphy. AJR Am J Roentgenol 137 (1981) 983-990
21. Procacci C., Fugazzola C., Cinquino M., et al. Contribution of CT to characterization of focal nodular hyperplasia of the liver. Gastrointest Radiol 17 (1992) 63-73
22. Brancatelli G., Federle M.P., Grazioli L., et al. Focal nodular hyperplasia: CT findings with emphasis on multiphasic helical CT in 78 patients. Radiology 219 (2001) 61-68
23. Lin M.C., Tsay P.K., Ko S.F., et al. Triphasic dynamic CT findings of 63 hepatic focal nodular hyperplasia in 46 patients: Correlation with size and pathological findings. Abdom Imaging 33 (2008) 301-307
24. Carlson S.K., Johnson C.D., Bender C.E., et al. Of focal nodular hyperplasia of the liver. AJR Am J Roentgenol 174 (2000) 705-712
25. Shirkhoda A., Farah M.C., Bernacki E., et al. Hepatic focal nodular hyperplasia: CT and sonographic spectrum. Abdom Imaging 19 (1994) 34-38
26. Caseiro-Alves F., Zins M., Mahfouz A.E., et al. Calcification in focal nodular hyperplasia: A new problem for differentiation from fibrolamellar hepatocellular carcinoma. Radiology 198 (1996) 889-892
27. Choi C.S., and Freeny P.C. Triphasic helical CT of hepatic focal nodular hyperplasia: Incidence of atypical findings. AJR Am J Roentgenol 170 (1998) 391-395
28. Cherqui D., Rahmouni A., Charlotte F., et al. Management of focal nodular hyperplasia and hepatocellular adenoma in young women: A series of 41 patients with clinical, radiological, and pathological correlations. J Hepatol 22 (1995) 1674-1681
29. Mortele K.J., Praet M., Van Vlierberghe H., et al. CT and MR imaging findings in focal nodular hyperplasia of the liver: Radiologic-pathologic correlation. AJR Am J Roentgenol 175 (2000) 687-692
30. Grazioli L., Morana G., Kirchin M.A., et al. Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: Prospective study. Radiology 236 (2005) 166-177
31. Ba-Ssalamah A., Schima W., Schmook M.T., et al. Atypical focal nodular hyperplasia of the liver: Imaging features of nonspecific and liver-specific MR contrast agents. AJR Am J Roentgenol 179 (2002) 1447-1456
32. Stanley G., Jeffrey Jr. R.B., and Feliz B. Findings and histopathology of intratumoral steatosis in focal nodular hyperplasia: Case report and review of the literature. J Comput Assist Tomogr 26 (2002) 815-817
33. Davis L.P., and Mccarroll K. Correlative imaging of the liver and hepatobiliary system. Semin Nucl Med 24 (1994) 208-218
34. Boulahdour H., Cherqui D., Charlotte F., et al. The hot spot hepatobiliary scan in focal nodular hyperplasia. J Nucl Med 34 (1993) 2105-2110
35. Kobayashi S., Matsui O., Gabata T., et al. Radiological and histopathological manifestations of hepatocellular nodular lesions concomitant with various congenital and acquired hepatic hemodynamic abnormalities. Jpn J Radiol 27 (2009) 53-68
36. Vilgrain V., Lewin M., Vons C., et al. Hepatic nodules in Budd-Chiari syndrome: Imaging features. Radiology 210 (1999) 443-450
37. Flor N., Zuin M., Brovelli F., et al. Regenerative nodules in patients with chronic Budd-Chiari syndrome: A longitudinal study using multiphase contrast-enhanced multidetector CT (2009), Eur J Radiol [epub ahead of print]
38. Qayyum A., Graser A., Westphalen A., et al. Of benign hypervascular liver nodules in autoimmune hepatitis. AJR Am J Roentgenol 183 (2004) 1573-1576
39. Moucari R., Rautou P.E., Cazals-Hatem D., et al. Hepatocellular carcinoma in Budd-Chiari syndrome: Characteristics and risk factors. Gut 57 (2008) 828-835
40. Maetani Y., Itoh K., Egawa H., et al. Benign hepatic nodules in Budd-Chiari syndrome: Radiologic-pathologic correlation with emphasis on the central scar. AJR Am J Roentgenol 178 (2002) 869-875
41. Reddy K.R., and Schiff E.R. Approach to a liver mass. Semin Liver Dis 13 (1993) 423-435
42. Soe K.L., Soe M., and Gluud C. Liver pathology associated with the use of anabolic-androgenic steroids. Liver 12 (1992) 73-79
43. Lee P.J. Glycogen storage disease type i: Pathophysiology of liver adenomas. Eur J Pediatr 161 (2002) S46-S49 1(suppl)
44. Franco L.M., Krishnamurthy V., Bali D., et al. Hepatocellular carcinoma in glycogen storage disease type IA: A case series. J Inherit Metab Dis 28 (2005) 153-162
45. Hussain S.M., van den Bos I.C., Dwarkasing R.S., et al. Hepatocellular adenoma: Findings at state-of-the-art magnetic resonance imaging, ultrasound, computed tomography and pathologic analysis. Eur Radiol 16 (2006) 1873-1886
46. Golli M., Van Nhieu J.T., Mathieu D., et al. Hepatocellular adenoma: Color Doppler US and pathologic correlations. Radiology 190 (1994) 741-744
47. Ichikawa T., Federle M.P., Grazioli L., et al. Hepatocellular adenoma: Multiphasic CT and histopathologic findings in 25 patients. Radiology 214 (2000) 861-868
48. Arrive L., Flejou J.F., Vilgrain V., et al. Hepatic adenoma: MR findings in 51 pathologically proved lesions. Radiology 193 (1994) 507-512
49. Mettler F.A., and Guiberteau M.J. Essentials of Nuclear Medicine Imaging. [Print], vol XI (2006), Saunders/Elsevier, Philadelphia, PA
50. Brancatelli G., Federle M.P., Vullierme M.P., et al. CT and MR imaging evaluation of hepatic adenoma. J Comput Assist Tomogr 30 (2006) 745-750
51. Parkin D.M., Bray F., Ferlay J., et al. Global cancer statistics, 2002. CA Cancer J Clin 55 2 (2005) 74-108
52. Davila J.A., Morgan R.O., Shaib Y., et al. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: A population-based study. Gastroenterology 127 (2004) 1372-1380
53. Llovet J.M., Burroughs A., and Bruix J. Hepatocellular carcinoma. Lancet 362 (2003) 1907-1917
54. El-Serag H.B., and Mason A.C. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340 (1999) 745-750
55. Mazzaferro V., Regalia E., Doci R., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334 (1996) 693-699
56. Freeman Jr. R.B. Transplantation for hepatocellular carcinoma: The Milan criteria and beyond. Liver Transplant 12 suppl 2 (2006) S8-S13
57. Yao F.Y., Ferrell L., Bass N.M., et al. Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival. J Hepatol 33 (2001) 1394-1403
58. Colli A., Fraquelli M., Casazza G., et al. Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: A systematic review. Am J Gastroenterol 101 (2006) 513-523
59. Willatt J.M., Hussain H.K., Adusumilli S., et al. MR imaging of hepatocellular carcinoma in the cirrhotic liver: Challenges and controversies. Radiology 247 (2008) 311-330
60. Baron R.L., and Brancatelli G. Computed tomographic imaging of hepatocellular carcinoma. Gastroenterology 127 suppl 1 (2004) S133-S143
61. Hollett M.D., Jeffrey Jr. R.B., Nino-Murcia M., et al. Dual-phase helical CT of the liver: Value of arterial phase scans in the detection of small (< or = 1.5 cm) malignant hepatic neoplasms. AJR Am J Roentgenol 164 (1995) 879-884
62. Hwang G.J., Kim M.J., Yoo H.S., et al. Nodular hepatocellular carcinomas: Detection with arterial-, portal-, and delayed-phase images at spiral CT. Radiology 202 (1997) 383-388
63. Kim T., Murakami T., Takahashi S., et al. Optimal phases of dynamic CT for detecting hepatocellular carcinoma: Evaluation of unenhanced and triple-phase images. Abdom Imaging 24 (1999) 473-480
64. Laghi A., Iannaccone R., Rossi P., et al. Hepatocellular carcinoma: Detection with triple-phase multi-detector row helical CT in patients with chronic hepatitis. Radiology 226 (2003) 543-549
65. Mitsuzaki K., Yamashita Y., Ogata I., et al. Multiple-phase helical CT of the liver for detecting small hepatomas in patients with liver cirrhosis: Contrast-injection protocol and optimal timing. AJR Am J Roentgenol 167 (1996) 753-757
66. Monzawa S., Ichikawa T., Nakajima H., et al. Dynamic CT for detecting small hepatocellular carcinoma: Usefulness of delayed phase imaging. AJR Am J Roentgenol 188 (2007) 147-153
67. Valls C., Cos M., Figueras J., et al. Pretransplantation diagnosis and staging of hepatocellular carcinoma in patients with cirrhosis: Value of dual-phase helical CT. AJR Am J Roentgenol 182 (2004) 1011-1017
68. Ronzoni A., Artioli D., Scardina R., et al. Role of MDCT in the diagnosis of hepatocellular carcinoma in patients with cirrhosis undergoing orthotopic liver transplantation. AJR Am J Roentgenol 189 (2007) 792-798
69. Marrero J.A., Hussain H.K., Nghiem H.V., et al. Improving the prediction of hepatocellular carcinoma in cirrhotic patients with an arterially-enhancing liver mass. Liver Transplant 11 (2005) 281-289
70. Bruix J., and Sherman M. Management of hepatocellular carcinoma. J Hepatol 42 (2005) 1208-1236
71. Iannaccone R., Laghi A., Catalano C., et al. Hepatocellular carcinoma: Role of unenhanced and delayed phase multi-detector row helical CT in patients with cirrhosis. Radiology 234 (2005) 460-467
72. Vauthey J.N., Lauwers G.Y., Esnaola N.F., et al. Simplified staging for hepatocellular carcinoma. J Clin Oncol 20 (2002) 1527-1536
73. Edmondson H.A. Differential diagnosis of tumors and tumor-like lesions of liver in infancy and childhood. AMA J Dis Child 91 (1956) 168-186
74. El-Serag H.B., and Davila J.A. Is fibrolamellar carcinoma different from hepatocellular carcinoma?. A US population-based study. J Hepatol 39 (2004) 798-803
75. Torbenson M. Review of the clinicopathologic features of fibrolamellar carcinoma. Adv Anat Pathol 14 (2007) 217-223
76. Ichikawa T., Federle M.P., Grazioli L., et al. Fibrolamellar hepatocellular carcinoma: Imaging and pathologic findings in 31 recent cases. Radiology 213 (1999) 352-361
77. McLarney J.K., Rucker P.T., Bender G.N., et al. Fibrolamellar carcinoma of the liver: Radiologic-pathologic correlation. RadioGraphics 19 (1999) 453-471
78. Brandt D.J., Johnson C.D., Stephens D.H., et al. Imaging of fibrolamellar hepatocellular carcinoma. AJR Am J Roentgenol 151 (1988) 295-299
79. Friedman A.C., Lichtenstein J.E., Goodman Z., et al. Fibrolamellar hepatocellular carcinoma. Radiology 157 (1985) 583-587
80. Powers C., Ros P.R., Stoupis C., et al. Primary liver neoplasms: MR imaging with pathologic correlation. RadioGraphics 14 (1994) 459-482
81. Katzenstein H.M., Krailo M.D., Malogolowkin M.H., et al. Fibrolamellar hepatocellular carcinoma in children and adolescents. Cancer 97 (2003) 2006-2012
82. Nakeeb A., Pitt H.A., Sohn T.A., et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 224 (1996) 463-473 discussion, 473-475
83. Sainani N.I., Catalano O.A., Holalkere N.S., et al. Cholangiocarcinoma: Current and novel imaging techniques. RadioGraphics 28 (2008) 1263-1287
84. Valls C., Guma A., Puig I., et al. Intrahepatic peripheral cholangiocarcinoma: CT evaluation. Abdom Imaging 25 (2000) 490-496
85. Chen M.F. Peripheral cholangiocarcinoma (cholangiocellular carcinoma): Clinical features, diagnosis and treatment. J Gastroenterol Hepatol 14 (1999) 1144-1149
86. Okuda K. Peripheral cholangiocarcinoma and intrahepatic calculi. J Gastroenterol Hepatol 14 (1999) 1141-1143
87. Hamrick-Turner J., Abbitt P.L., and Ros P.R. Intrahepatic cholangiocarcinoma: MR appearance. AJR Am J Roentgenol 158 (1992) 77-79
88. Loyer E.M., Chin H., Dubrow R.A., et al. Hepatocellular carcinoma and intrahepatic peripheral cholangiocarcinoma: Enhancement patterns with quadruple phase helical CT-A comparative study. Radiology 212 (1999) 866-875
89. Kim Y.J., Yun M., Lee W.J., et al. Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma. Eur J Nucl Med Mol Imaging 30 (2003) 1467-1472
90. Torabi M., Hosseinzadeh K., and Federle M.P. Of nonneoplastic hepatic vascular and perfusion disorders. RadioGraphics 28 (2008) 1967-1982
91. Lane M.J., Jeffrey Jr. R.B., and Katz D.S. Spontaneous intrahepatic vascular shunts. AJR Am J Roentgenol 174 (2000) 125-131
92. Colagrande S., Centi N., Galdiero R., et al. Transient hepatic intensity differences. Part 2, Those not associated with focal lesions. AJR Am J Roentgenol 188 1 (2007) 160-166
93. Takayasu K., Muramatsu Y., Mizuguchi Y., et al. Multiple non-tumorous arterioportal shunts due to chronic liver disease mimicking hepatocellular carcinoma: Outcomes and the associated elevation of alpha-fetoprotein. J Gastroenterol Hepatol 21 (2006) 288-294
94. Guttmacher A.E., Marchuk D.A., and White Jr. R.I. Hereditary hemorrhagic telangiectasia. N Engl J Med 333 (1995) 918-924
95. Garcia-Tsao G., Korzenik J.R., Young L., et al. Liver disease in patients with hereditary hemorrhagic telangiectasia. N Engl J Med 343 (2000) 931-936
96. Wu J.S., Saluja S., Garcia-Tsao G., et al. Liver involvement in hereditary hemorrhagic telangiectasia: CT and clinical findings do not correlate in symptomatic patients. AJR Am J Roentgenol 187 (2006) W399-W405
97. Ianora A.A., Memeo M., Sabba C., et al. Hereditary hemorrhagic telangiectasia: Multi-detector row helical CT assessment of hepatic involvement. Radiology 230 (2004) 250-259
98. Siddiki H., Doherty M.G., Fletcher J.G., et al. Abdominal findings in hereditary hemorrhagic telangiectasia: Pictorial essay on 2D and 3D findings with isotropic multiphase CT. RadioGraphics 28 (2008) 171-184
99. Buscarini E., Danesino C., Plauchu H., et al. High prevalence of hepatic focal nodular hyperplasia in subjects with hereditary hemorrhagic telangiectasia. Ultrasound Med Biol 30 (2004) 1089-1097
100. Milot L., Kamaoui I., Gautier G., et al. Hereditary-hemorrhagic telangiectasia: One-step magnetic resonance examination in evaluation of liver involvement. Gastroenterol Clin Biol 32 (2008) 677-685
101. Buonamico P., Suppressa P., Lenato G.M., et al. Liver involvement in a large cohort of patients with hereditary hemorrhagic telangiectasia: Echo-color-Doppler vs multislice computed tomography study. J Hepatol 48 (2008) 811-820
102. Naganuma H., Ishida H., Niizawa M., et al. Hepatic involvement in Osler-Weber-Rendu disease: Findings on pulsed and color Doppler sonography. AJR Am J Roentgenol 165 (1995) 1421-1425
103. Bertolotto M., Martinoli C., Migaleddu V., et al. Color Doppler sonography of intrahepatic vascular shunts. J Clin Ultrasound 36 (2008) 527-538
104. Bioulac-Sage P., Laumonier H., Laurent C., et al. Benign and malignant vascular tumors of the liver in adults. Semin Liver Dis 28 (2008) 302-314
105. Kassarjian A., Zurakowski D., Dubois J., et al. Infantile hepatic hemangiomas: Clinical and imaging findings and their correlation with therapy. AJR Am J Roentgenol 182 (2004) 785-795
106. Shimizu M., Miura J., Itoh H., et al. Hepatic giant cavernous hemangioma with microangiopathic hemolytic anemia and consumption coagulopathy. Am J Gastroenterol 85 (1990) 1411-1413
107. Corigliano N., Mercantini P., Amodio P.M., et al. Hemoperitoneum from a spontaneous rupture of a giant hemangioma of the liver: Report of a case. Surg Today 33 (2003) 459-463
108. Kim K.W., Kim A.Y., Kim T.K., et al. Hepatic hemangiomas with arterioportal shunt: Sonographic appearances with CT and MRI correlation. AJR Am J Roentgenol 187 (2006) W406-W414
109. Kobayashi S., Maruyama H., Okugawa H., et al. Contrast-enhanced US with levovist for the diagnosis of hepatic hemangioma: Time-related changes of enhancement appearance and the hemodynamic background. Hepatogastroenterology 55 (2008) 1222-1228
110. Dietrich C.F., Mertens J.C., Braden B., et al. Contrast-enhanced ultrasound of histologically proven liver hemangiomas. J Hepatol 45 (2007) 1139-1145
111. Yamashita Y., Ogata I., Urata J., et al. Cavernous hemangioma of the liver: Pathologic correlation with dynamic CT findings. Radiology 203 (1997) 121-125
112. Coumbaras M., Wendum D., Monnier-Cholley L., et al. CT and MR imaging features of pathologically proven atypical giant hemangiomas of the liver. AJR Am J Roentgenol 179 (2002) 1457-1463
113. Federle M., and Anne V. Hepatic Cavernous Hemangioma: Diagnostic Imaging: Abdomen. (ed 1) (2004), Amirsys, Inc, Salt Lake City, UT
114. Bhati C.S., Bhatt A.N., Starkey G., et al. Acute liver failure due to primary angiosarcoma: A case report and review of literature. World J Surg Oncol 6 (2008) 104
115. Koyama T., Fletcher J.G., Johnson C.D., et al. Primary hepatic angiosarcoma: Findings at CT and MR imaging. Radiology 222 (2002) 667-673
116. Kim H.R., Rha S.Y., Cheon S.H., et al. Clinical features and treatment outcomes of advanced stage primary hepatic angiosarcoma. Ann Oncol 20 (2009) 780-787
117. Molina E., and Hernandez A. Clinical manifestations of primary hepatic angiosarcoma. Digest Dis Sci 48 (2003) 677-682
118. Lee S.W., Song C.Y., Gi Y.H., et al. Hepatic angiosarcoma manifested as recurrent hemoperitoneum. World J Gastroenterol 14 (2008) 2935-2938
119. Yu R.S., Chen Y., Jiang B., et al. Primary hepatic sarcomas: CT findings. Eur Radiol 18 (2008) 2196-2205
120. Peterson M.S., Baron R.L., and Rankin S.C. Hepatic angiosarcoma: Findings on multiphasic contrast-enhanced helical CT do not mimic hepatic hemangioma. AJR Am J Roentgenol 175 (2000) 165-170
121. Maeda T., Tateishi U., Hasegawa T., et al. Primary hepatic angiosarcoma on coregistered FDG PET and CT images. AJR Am J Roentgenol 188 (2007) 1615-1617
122. Abbott R.M., Levy A.D., Aguilera N.S., et al. From the archives of the AFIP: Primary vascular neoplasms of the spleen: Radiologic-pathologic correlation. RadioGraphics 24 (2004) 1137-1163
123. Tsokos M., and Erbersdobler A. Pathology of peliosis. Forensic Sci Int 149 (2005) 25-33
124. Kim S.H., Lee J.M., Kim W.H., et al. Focal peliosis hepatis as a mimicker of hepatic tumors: Radiological-pathological correlation. J Comput Assist Tomogr 31 (2007) 79-85
125. Iannaccone R., Federle M.P., Brancatelli G., et al. Peliosis hepatis: Spectrum of imaging findings. AJR Am J Roentgenol 187 (2006) W43-W52
126. Jaiswal V.R., Champine J.G., Sharma S., et al. Primary glomangioma of the liver: A case report and review of the literature. Arch Pathol Lab Med 128 (2004) e46-e49
127. Kenn W., Klein I., Gassel H.J., et al. Primary glomangioma of the liver: Imaging findings. Abdom Imaging 27 (2002) 716-719
128. Gombos Z., and Zhang P.J. Glomus tumor. Arch Pathol Lab Med 132 (2008) 1448-1452
129. Yan F.H., Zhou K.R., Jiang Y.P., et al. Inflammatory pseudotumor of the liver: 13 cases of MRI findings. World J Gastroenterol 7 (2001) 422-424
130. Fukuya T., Honda H., Matsumata T., et al. Diagnosis of inflammatory pseudotumor of the liver: Value of CT. AJR Am J Roentgenol 163 (1994) 1087-1091
131. Yoon K.H., Ha H.K., Lee J.S., et al. Inflammatory pseudotumor of the liver in patients with recurrent pyogenic cholangitis: CT-histopathologic correlation. Radiology 211 (1999) 373-379
132. Nam K.J., Kang H.K., and Lim J.H. Inflammatory pseudotumor of the liver: CT and sonographic findings. AJR Am J Roentgenol 167 (1996) 485-487
133. Ros P.R., and Taylor H.M. Malignant tumors of the liver. In: Gore R.M., and Levine M.S. (Eds). Textbook of Gastrointestinal Radiology (2000), WB Saunders, Philadelphia, PA 1523-1568
134. Silva A.C., Evans J.M., Mccullough A.E., et al. MR imaging of hypervascular liver masses: A review of current techniques. RadioGraphics 29 (2009) 385-402
135. Namasivayam S., Martin D.R., and Saini S. Imaging of liver metastases: MRI. Cancer Imaging 7 (2007) 2-9
136. Danet I.M., Semelka R.C., Leonardou P., et al. Spectrum of MRI appearances of untreated metastases of the liver. AJR Am J Roentgenol 181 (2003) 809-817
137. Sica G.T., Ji H., and Ros P.R. CT and MR imaging of hepatic metastases. AJR Am J Roentgenol 174 (2000) 691-698
138. Burkholz K.J., Silva A.C., and File A.J.R.T. Hypervascular metastasis or hepatic hemangioma?. AJR Am J Roentgenol 190 suppl (2008) S53-S56
139. Mahfouz A.E., Hamm B., and Wolf K.J. Peripheral washout: A sign of malignancy on dynamic gadolinium-enhanced MR images of focal liver lesions. Radiology 190 (1994) 49-52
140. Quillin S.P., Atilla S., Brown J.J., et al. Characterization of focal hepatic masses by dynamic contrast-enhanced MR imaging: Findings in 311 lesions. Magn Reson Imaging 15 (1997) 275-285